nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Breast disorder—Temozolomide—melanoma	0.00394	0.00397	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00393	0.00395	CcSEcCtD
Gemifloxacin—Dysphagia—Carmustine—melanoma	0.0039	0.00393	CcSEcCtD
Gemifloxacin—Stomatitis—Bleomycin—melanoma	0.00388	0.00391	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Temozolomide—melanoma	0.00385	0.00387	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00382	0.00385	CcSEcCtD
Gemifloxacin—Candida infection—Docetaxel—melanoma	0.00382	0.00384	CcSEcCtD
Gemifloxacin—Skin exfoliation—Docetaxel—melanoma	0.00382	0.00384	CcSEcCtD
Gemifloxacin—Haematuria—Bleomycin—melanoma	0.0038	0.00382	CcSEcCtD
Gemifloxacin—Dysphagia—Temozolomide—melanoma	0.00377	0.0038	CcSEcCtD
Gemifloxacin—Pneumonia—Dactinomycin—melanoma	0.00374	0.00376	CcSEcCtD
Gemifloxacin—Decreased appetite—Vemurafenib—melanoma	0.00365	0.00367	CcSEcCtD
Gemifloxacin—Stomatitis—Dactinomycin—melanoma	0.00362	0.00365	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Vemurafenib—melanoma	0.00362	0.00365	CcSEcCtD
Gemifloxacin—Fatigue—Vemurafenib—melanoma	0.00362	0.00364	CcSEcCtD
Gemifloxacin—Haemoglobin—Bleomycin—melanoma	0.0036	0.00362	CcSEcCtD
Gemifloxacin—Constipation—Vemurafenib—melanoma	0.00359	0.00361	CcSEcCtD
Gemifloxacin—Haemorrhage—Bleomycin—melanoma	0.00358	0.0036	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Carmustine—melanoma	0.00352	0.00354	CcSEcCtD
Gemifloxacin—Pneumonia—Carmustine—melanoma	0.0035	0.00352	CcSEcCtD
Gemifloxacin—Agranulocytosis—Dactinomycin—melanoma	0.00347	0.00349	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Temozolomide—melanoma	0.00344	0.00346	CcSEcCtD
Gemifloxacin—Renal failure—Carmustine—melanoma	0.00342	0.00344	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Carmustine—melanoma	0.00341	0.00343	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Temozolomide—melanoma	0.0034	0.00342	CcSEcCtD
Gemifloxacin—Stomatitis—Carmustine—melanoma	0.00339	0.00341	CcSEcCtD
Gemifloxacin—Pneumonia—Temozolomide—melanoma	0.00338	0.0034	CcSEcCtD
Gemifloxacin—Infestation NOS—Temozolomide—melanoma	0.00336	0.00338	CcSEcCtD
Gemifloxacin—Infestation—Temozolomide—melanoma	0.00336	0.00338	CcSEcCtD
Gemifloxacin—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00334	0.00336	CcSEcCtD
Gemifloxacin—Flushing—Bleomycin—melanoma	0.00332	0.00334	CcSEcCtD
Gemifloxacin—Body temperature increased—Vemurafenib—melanoma	0.00332	0.00334	CcSEcCtD
Gemifloxacin—Pharyngitis—Dactinomycin—melanoma	0.00331	0.00333	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Temozolomide—melanoma	0.0033	0.00332	CcSEcCtD
Gemifloxacin—Stomatitis—Temozolomide—melanoma	0.00328	0.0033	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Temozolomide—melanoma	0.00318	0.0032	CcSEcCtD
Gemifloxacin—Erythema multiforme—Dactinomycin—melanoma	0.00315	0.00318	CcSEcCtD
Gemifloxacin—Haemoglobin—Carmustine—melanoma	0.00314	0.00316	CcSEcCtD
Gemifloxacin—Haemorrhage—Carmustine—melanoma	0.00312	0.00314	CcSEcCtD
Gemifloxacin—Hot flush—Docetaxel—melanoma	0.0031	0.00312	CcSEcCtD
Gemifloxacin—Flushing—Dactinomycin—melanoma	0.0031	0.00312	CcSEcCtD
Gemifloxacin—Oedema peripheral—Carmustine—melanoma	0.00308	0.0031	CcSEcCtD
Gemifloxacin—Menopausal symptoms—Docetaxel—melanoma	0.00307	0.00309	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Carmustine—melanoma	0.00307	0.00309	CcSEcCtD
Gemifloxacin—Haemoglobin—Temozolomide—melanoma	0.00303	0.00305	CcSEcCtD
Gemifloxacin—Haemorrhage—Temozolomide—melanoma	0.00302	0.00304	CcSEcCtD
Gemifloxacin—Asthenia—Vemurafenib—melanoma	0.00301	0.00303	CcSEcCtD
Gemifloxacin—Visual impairment—Carmustine—melanoma	0.00301	0.00303	CcSEcCtD
Gemifloxacin—Pharyngitis—Temozolomide—melanoma	0.003	0.00301	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Temozolomide—melanoma	0.00298	0.003	CcSEcCtD
Gemifloxacin—Oedema peripheral—Temozolomide—melanoma	0.00297	0.00299	CcSEcCtD
Gemifloxacin—Pruritus—Vemurafenib—melanoma	0.00297	0.00299	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Temozolomide—melanoma	0.00297	0.00299	CcSEcCtD
Gemifloxacin—Urethral disorder—Temozolomide—melanoma	0.00296	0.00298	CcSEcCtD
Gemifloxacin—Eye disorder—Carmustine—melanoma	0.00292	0.00294	CcSEcCtD
Gemifloxacin—Hyponatraemia—Docetaxel—melanoma	0.00291	0.00293	CcSEcCtD
Gemifloxacin—Visual impairment—Temozolomide—melanoma	0.00291	0.00293	CcSEcCtD
Gemifloxacin—Flushing—Carmustine—melanoma	0.0029	0.00292	CcSEcCtD
Gemifloxacin—Anaemia—Bleomycin—melanoma	0.00288	0.0029	CcSEcCtD
Gemifloxacin—Diarrhoea—Vemurafenib—melanoma	0.00287	0.00289	CcSEcCtD
Gemifloxacin—Erythema multiforme—Temozolomide—melanoma	0.00285	0.00287	CcSEcCtD
Gemifloxacin—Eye disorder—Temozolomide—melanoma	0.00282	0.00284	CcSEcCtD
Gemifloxacin—Cardiac disorder—Temozolomide—melanoma	0.0028	0.00282	CcSEcCtD
Gemifloxacin—Flushing—Temozolomide—melanoma	0.0028	0.00282	CcSEcCtD
Gemifloxacin—Leukopenia—Bleomycin—melanoma	0.00279	0.00281	CcSEcCtD
Gemifloxacin—Dizziness—Vemurafenib—melanoma	0.00277	0.00279	CcSEcCtD
Gemifloxacin—Angiopathy—Temozolomide—melanoma	0.00274	0.00276	CcSEcCtD
Gemifloxacin—Mental disorder—Carmustine—melanoma	0.00274	0.00275	CcSEcCtD
Gemifloxacin—Immune system disorder—Temozolomide—melanoma	0.00273	0.00274	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Temozolomide—melanoma	0.00272	0.00274	CcSEcCtD
Gemifloxacin—Anaemia—Dactinomycin—melanoma	0.00268	0.0027	CcSEcCtD
Gemifloxacin—Vomiting—Vemurafenib—melanoma	0.00267	0.00269	CcSEcCtD
Gemifloxacin—Gatifloxacin—ALB—melanoma	0.00267	0.403	CrCbGaD
Gemifloxacin—Myalgia—Bleomycin—melanoma	0.00265	0.00267	CcSEcCtD
Gemifloxacin—Rash—Vemurafenib—melanoma	0.00265	0.00266	CcSEcCtD
Gemifloxacin—Mental disorder—Temozolomide—melanoma	0.00264	0.00266	CcSEcCtD
Gemifloxacin—Dermatitis—Vemurafenib—melanoma	0.00264	0.00266	CcSEcCtD
Gemifloxacin—Back pain—Carmustine—melanoma	0.00263	0.00265	CcSEcCtD
Gemifloxacin—Headache—Vemurafenib—melanoma	0.00263	0.00265	CcSEcCtD
Gemifloxacin—Breast disorder—Docetaxel—melanoma	0.00262	0.00264	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00261	0.00263	CcSEcCtD
Gemifloxacin—Leukopenia—Dactinomycin—melanoma	0.0026	0.00262	CcSEcCtD
Gemifloxacin—Dysgeusia—Temozolomide—melanoma	0.00257	0.00259	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Docetaxel—melanoma	0.00256	0.00258	CcSEcCtD
Gemifloxacin—Tremor—Carmustine—melanoma	0.00255	0.00256	CcSEcCtD
Gemifloxacin—Oedema—Bleomycin—melanoma	0.00254	0.00256	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Bleomycin—melanoma	0.00254	0.00256	CcSEcCtD
Gemifloxacin—Back pain—Temozolomide—melanoma	0.00254	0.00256	CcSEcCtD
Gemifloxacin—Anaemia—Carmustine—melanoma	0.00251	0.00253	CcSEcCtD
Gemifloxacin—Dysphagia—Docetaxel—melanoma	0.00251	0.00252	CcSEcCtD
Gemifloxacin—Nausea—Vemurafenib—melanoma	0.00249	0.00251	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Bleomycin—melanoma	0.00249	0.00251	CcSEcCtD
Gemifloxacin—Myalgia—Dactinomycin—melanoma	0.00247	0.00249	CcSEcCtD
Gemifloxacin—Tremor—Temozolomide—melanoma	0.00246	0.00248	CcSEcCtD
Gemifloxacin—Leukopenia—Carmustine—melanoma	0.00243	0.00245	CcSEcCtD
Gemifloxacin—Anaemia—Temozolomide—melanoma	0.00243	0.00244	CcSEcCtD
Gemifloxacin—Anorexia—Bleomycin—melanoma	0.00242	0.00244	CcSEcCtD
Gemifloxacin—Oedema—Dactinomycin—melanoma	0.00237	0.00239	CcSEcCtD
Gemifloxacin—Vertigo—Temozolomide—melanoma	0.00236	0.00238	CcSEcCtD
Gemifloxacin—Leukopenia—Temozolomide—melanoma	0.00235	0.00237	CcSEcCtD
Gemifloxacin—Palpitations—Temozolomide—melanoma	0.00232	0.00234	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Dactinomycin—melanoma	0.00232	0.00234	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Bleomycin—melanoma	0.00232	0.00233	CcSEcCtD
Gemifloxacin—Myalgia—Carmustine—melanoma	0.00231	0.00233	CcSEcCtD
Gemifloxacin—Dyspnoea—Bleomycin—melanoma	0.00227	0.00228	CcSEcCtD
Gemifloxacin—Anorexia—Dactinomycin—melanoma	0.00226	0.00227	CcSEcCtD
Gemifloxacin—Pneumonia—Docetaxel—melanoma	0.00225	0.00226	CcSEcCtD
Gemifloxacin—Arthralgia—Temozolomide—melanoma	0.00224	0.00225	CcSEcCtD
Gemifloxacin—Myalgia—Temozolomide—melanoma	0.00224	0.00225	CcSEcCtD
Gemifloxacin—Infestation—Docetaxel—melanoma	0.00224	0.00225	CcSEcCtD
Gemifloxacin—Infestation NOS—Docetaxel—melanoma	0.00224	0.00225	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00222	0.00224	CcSEcCtD
Gemifloxacin—Oedema—Carmustine—melanoma	0.00222	0.00223	CcSEcCtD
Gemifloxacin—Decreased appetite—Bleomycin—melanoma	0.00221	0.00222	CcSEcCtD
Gemifloxacin—Renal failure—Docetaxel—melanoma	0.0022	0.00221	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Docetaxel—melanoma	0.00219	0.00221	CcSEcCtD
Gemifloxacin—Dry mouth—Temozolomide—melanoma	0.00219	0.0022	CcSEcCtD
Gemifloxacin—Stomatitis—Docetaxel—melanoma	0.00218	0.00219	CcSEcCtD
Gemifloxacin—Pain—Bleomycin—melanoma	0.00217	0.00219	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Carmustine—melanoma	0.00217	0.00219	CcSEcCtD
Gemifloxacin—Tachycardia—Carmustine—melanoma	0.00217	0.00218	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00216	0.00217	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Temozolomide—melanoma	0.00214	0.00216	CcSEcCtD
Gemifloxacin—Oedema—Temozolomide—melanoma	0.00214	0.00216	CcSEcCtD
Gemifloxacin—Anorexia—Carmustine—melanoma	0.00211	0.00213	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Docetaxel—melanoma	0.00211	0.00213	CcSEcCtD
Gemifloxacin—Nervous system disorder—Temozolomide—melanoma	0.0021	0.00212	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Temozolomide—melanoma	0.0021	0.00211	CcSEcCtD
Gemifloxacin—Agranulocytosis—Docetaxel—melanoma	0.00209	0.0021	CcSEcCtD
Gemifloxacin—Skin disorder—Temozolomide—melanoma	0.00208	0.0021	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Temozolomide—melanoma	0.00207	0.00209	CcSEcCtD
Gemifloxacin—Decreased appetite—Dactinomycin—melanoma	0.00206	0.00207	CcSEcCtD
Gemifloxacin—Fatigue—Dactinomycin—melanoma	0.00204	0.00206	CcSEcCtD
Gemifloxacin—Anorexia—Temozolomide—melanoma	0.00204	0.00206	CcSEcCtD
Gemifloxacin—Pain—Dactinomycin—melanoma	0.00203	0.00204	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Carmustine—melanoma	0.00202	0.00203	CcSEcCtD
Gemifloxacin—Urticaria—Bleomycin—melanoma	0.00202	0.00203	CcSEcCtD
Gemifloxacin—Haemoglobin—Docetaxel—melanoma	0.00202	0.00203	CcSEcCtD
Gemifloxacin—Body temperature increased—Bleomycin—melanoma	0.00201	0.00202	CcSEcCtD
Gemifloxacin—Haemorrhage—Docetaxel—melanoma	0.00201	0.00202	CcSEcCtD
Gemifloxacin—Insomnia—Carmustine—melanoma	0.00201	0.00202	CcSEcCtD
Gemifloxacin—Pharyngitis—Docetaxel—melanoma	0.00199	0.00201	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Docetaxel—melanoma	0.00198	0.002	CcSEcCtD
Gemifloxacin—Dyspnoea—Carmustine—melanoma	0.00198	0.00199	CcSEcCtD
Gemifloxacin—Oedema peripheral—Docetaxel—melanoma	0.00198	0.00199	CcSEcCtD
Gemifloxacin—Somnolence—Carmustine—melanoma	0.00197	0.00199	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Docetaxel—melanoma	0.00197	0.00199	CcSEcCtD
Gemifloxacin—Urethral disorder—Docetaxel—melanoma	0.00197	0.00198	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Temozolomide—melanoma	0.00195	0.00197	CcSEcCtD
Gemifloxacin—Insomnia—Temozolomide—melanoma	0.00194	0.00195	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Dactinomycin—melanoma	0.00194	0.00195	CcSEcCtD
Gemifloxacin—Visual impairment—Docetaxel—melanoma	0.00193	0.00195	CcSEcCtD
Gemifloxacin—Decreased appetite—Carmustine—melanoma	0.00193	0.00194	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Carmustine—melanoma	0.00192	0.00193	CcSEcCtD
Gemifloxacin—Dyspnoea—Temozolomide—melanoma	0.00191	0.00192	CcSEcCtD
Gemifloxacin—Somnolence—Temozolomide—melanoma	0.00191	0.00192	CcSEcCtD
Gemifloxacin—Erythema multiforme—Docetaxel—melanoma	0.0019	0.00191	CcSEcCtD
Gemifloxacin—Constipation—Carmustine—melanoma	0.0019	0.00191	CcSEcCtD
Gemifloxacin—Pain—Carmustine—melanoma	0.0019	0.00191	CcSEcCtD
Gemifloxacin—Dyspepsia—Temozolomide—melanoma	0.00189	0.0019	CcSEcCtD
Gemifloxacin—Eye disorder—Docetaxel—melanoma	0.00188	0.00189	CcSEcCtD
Gemifloxacin—Abdominal pain—Dactinomycin—melanoma	0.00187	0.00189	CcSEcCtD
Gemifloxacin—Body temperature increased—Dactinomycin—melanoma	0.00187	0.00189	CcSEcCtD
Gemifloxacin—Decreased appetite—Temozolomide—melanoma	0.00186	0.00188	CcSEcCtD
Gemifloxacin—Flushing—Docetaxel—melanoma	0.00186	0.00187	CcSEcCtD
Gemifloxacin—Cardiac disorder—Docetaxel—melanoma	0.00186	0.00187	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Temozolomide—melanoma	0.00185	0.00186	CcSEcCtD
Gemifloxacin—Fatigue—Temozolomide—melanoma	0.00185	0.00186	CcSEcCtD
Gemifloxacin—Constipation—Temozolomide—melanoma	0.00183	0.00185	CcSEcCtD
Gemifloxacin—Pain—Temozolomide—melanoma	0.00183	0.00185	CcSEcCtD
Gemifloxacin—Asthenia—Bleomycin—melanoma	0.00182	0.00184	CcSEcCtD
Gemifloxacin—Angiopathy—Docetaxel—melanoma	0.00182	0.00183	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Carmustine—melanoma	0.00181	0.00183	CcSEcCtD
Gemifloxacin—Immune system disorder—Docetaxel—melanoma	0.00181	0.00182	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Docetaxel—melanoma	0.00181	0.00182	CcSEcCtD
Gemifloxacin—Pruritus—Bleomycin—melanoma	0.0018	0.00181	CcSEcCtD
Gemifloxacin—Mental disorder—Docetaxel—melanoma	0.00176	0.00177	CcSEcCtD
Gemifloxacin—Abdominal pain—Carmustine—melanoma	0.00175	0.00177	CcSEcCtD
Gemifloxacin—Body temperature increased—Carmustine—melanoma	0.00175	0.00177	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Temozolomide—melanoma	0.00175	0.00176	CcSEcCtD
Gemifloxacin—Dysgeusia—Docetaxel—melanoma	0.00171	0.00172	CcSEcCtD
Gemifloxacin—Urticaria—Temozolomide—melanoma	0.0017	0.00171	CcSEcCtD
Gemifloxacin—Asthenia—Dactinomycin—melanoma	0.0017	0.00171	CcSEcCtD
Gemifloxacin—Body temperature increased—Temozolomide—melanoma	0.00169	0.00171	CcSEcCtD
Gemifloxacin—Abdominal pain—Temozolomide—melanoma	0.00169	0.00171	CcSEcCtD
Gemifloxacin—Back pain—Docetaxel—melanoma	0.00169	0.0017	CcSEcCtD
Gemifloxacin—Muscle spasms—Docetaxel—melanoma	0.00168	0.00169	CcSEcCtD
Gemifloxacin—Sparfloxacin—ABCB1—melanoma	0.00166	0.251	CrCbGaD
Gemifloxacin—Diarrhoea—Dactinomycin—melanoma	0.00162	0.00163	CcSEcCtD
Gemifloxacin—Vomiting—Bleomycin—melanoma	0.00162	0.00163	CcSEcCtD
Gemifloxacin—Anaemia—Docetaxel—melanoma	0.00161	0.00163	CcSEcCtD
Gemifloxacin—Rash—Bleomycin—melanoma	0.0016	0.00161	CcSEcCtD
Gemifloxacin—Dermatitis—Bleomycin—melanoma	0.0016	0.00161	CcSEcCtD
Gemifloxacin—Asthenia—Carmustine—melanoma	0.00159	0.0016	CcSEcCtD
Gemifloxacin—Syncope—Docetaxel—melanoma	0.00157	0.00158	CcSEcCtD
Gemifloxacin—Leukopenia—Docetaxel—melanoma	0.00156	0.00157	CcSEcCtD
Gemifloxacin—Palpitations—Docetaxel—melanoma	0.00154	0.00155	CcSEcCtD
Gemifloxacin—Asthenia—Temozolomide—melanoma	0.00154	0.00155	CcSEcCtD
Gemifloxacin—Loss of consciousness—Docetaxel—melanoma	0.00154	0.00155	CcSEcCtD
Gemifloxacin—Diarrhoea—Carmustine—melanoma	0.00152	0.00153	CcSEcCtD
Gemifloxacin—Pruritus—Temozolomide—melanoma	0.00152	0.00153	CcSEcCtD
Gemifloxacin—Nausea—Bleomycin—melanoma	0.00151	0.00152	CcSEcCtD
Gemifloxacin—Vomiting—Dactinomycin—melanoma	0.00151	0.00152	CcSEcCtD
Gemifloxacin—Rash—Dactinomycin—melanoma	0.00149	0.0015	CcSEcCtD
Gemifloxacin—Myalgia—Docetaxel—melanoma	0.00149	0.0015	CcSEcCtD
Gemifloxacin—Arthralgia—Docetaxel—melanoma	0.00149	0.0015	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00148	0.00149	CcSEcCtD
Gemifloxacin—Dizziness—Carmustine—melanoma	0.00147	0.00148	CcSEcCtD
Gemifloxacin—Diarrhoea—Temozolomide—melanoma	0.00147	0.00148	CcSEcCtD
Gemifloxacin—Dry mouth—Docetaxel—melanoma	0.00145	0.00146	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Docetaxel—melanoma	0.00143	0.00144	CcSEcCtD
Gemifloxacin—Oedema—Docetaxel—melanoma	0.00143	0.00144	CcSEcCtD
Gemifloxacin—Dizziness—Temozolomide—melanoma	0.00142	0.00143	CcSEcCtD
Gemifloxacin—Vomiting—Carmustine—melanoma	0.00141	0.00142	CcSEcCtD
Gemifloxacin—Nausea—Dactinomycin—melanoma	0.00141	0.00142	CcSEcCtD
Gemifloxacin—Shock—Docetaxel—melanoma	0.0014	0.00141	CcSEcCtD
Gemifloxacin—Rash—Carmustine—melanoma	0.0014	0.00141	CcSEcCtD
Gemifloxacin—Nervous system disorder—Docetaxel—melanoma	0.0014	0.00141	CcSEcCtD
Gemifloxacin—Dermatitis—Carmustine—melanoma	0.0014	0.00141	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Docetaxel—melanoma	0.0014	0.00141	CcSEcCtD
Gemifloxacin—Tachycardia—Docetaxel—melanoma	0.00139	0.0014	CcSEcCtD
Gemifloxacin—Headache—Carmustine—melanoma	0.00139	0.0014	CcSEcCtD
Gemifloxacin—Skin disorder—Docetaxel—melanoma	0.00138	0.00139	CcSEcCtD
Gemifloxacin—Vomiting—Temozolomide—melanoma	0.00136	0.00137	CcSEcCtD
Gemifloxacin—Anorexia—Docetaxel—melanoma	0.00136	0.00137	CcSEcCtD
Gemifloxacin—Rash—Temozolomide—melanoma	0.00135	0.00136	CcSEcCtD
Gemifloxacin—Dermatitis—Temozolomide—melanoma	0.00135	0.00136	CcSEcCtD
Gemifloxacin—Headache—Temozolomide—melanoma	0.00134	0.00135	CcSEcCtD
Gemifloxacin—Nausea—Carmustine—melanoma	0.00132	0.00133	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Docetaxel—melanoma	0.0013	0.00131	CcSEcCtD
Gemifloxacin—Insomnia—Docetaxel—melanoma	0.00129	0.0013	CcSEcCtD
Gemifloxacin—Nausea—Temozolomide—melanoma	0.00127	0.00128	CcSEcCtD
Gemifloxacin—Dyspnoea—Docetaxel—melanoma	0.00127	0.00128	CcSEcCtD
Gemifloxacin—Somnolence—Docetaxel—melanoma	0.00127	0.00128	CcSEcCtD
Gemifloxacin—Dyspepsia—Docetaxel—melanoma	0.00126	0.00126	CcSEcCtD
Gemifloxacin—Decreased appetite—Docetaxel—melanoma	0.00124	0.00125	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Docetaxel—melanoma	0.00123	0.00124	CcSEcCtD
Gemifloxacin—Fatigue—Docetaxel—melanoma	0.00123	0.00124	CcSEcCtD
Gemifloxacin—Pain—Docetaxel—melanoma	0.00122	0.00123	CcSEcCtD
Gemifloxacin—Constipation—Docetaxel—melanoma	0.00122	0.00123	CcSEcCtD
Gemifloxacin—Levofloxacin—ABCB1—melanoma	0.00117	0.176	CrCbGaD
Gemifloxacin—Gastrointestinal pain—Docetaxel—melanoma	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Ciprofloxacin—ABCB1—melanoma	0.00113	0.17	CrCbGaD
Gemifloxacin—Abdominal pain—Docetaxel—melanoma	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Body temperature increased—Docetaxel—melanoma	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Asthenia—Docetaxel—melanoma	0.00102	0.00103	CcSEcCtD
Gemifloxacin—Pruritus—Docetaxel—melanoma	0.00101	0.00102	CcSEcCtD
Gemifloxacin—Diarrhoea—Docetaxel—melanoma	0.000976	0.000982	CcSEcCtD
Gemifloxacin—Dizziness—Docetaxel—melanoma	0.000943	0.000949	CcSEcCtD
Gemifloxacin—Vomiting—Docetaxel—melanoma	0.000907	0.000913	CcSEcCtD
Gemifloxacin—Rash—Docetaxel—melanoma	0.000899	0.000905	CcSEcCtD
Gemifloxacin—Dermatitis—Docetaxel—melanoma	0.000898	0.000904	CcSEcCtD
Gemifloxacin—Headache—Docetaxel—melanoma	0.000893	0.000899	CcSEcCtD
Gemifloxacin—Nausea—Docetaxel—melanoma	0.000847	0.000853	CcSEcCtD
